A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain
NCT ID: NCT02171182
Last Updated: 2016-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
319 participants
OBSERVATIONAL
2014-01-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage
NCT01252160
Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain
NCT03317613
Observation of the Use of QUTENZA™ in Standard Clinical Practice
NCT01737294
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
NCT04967664
Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch
NCT01416116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Qutenza patients w/ post-operative peripheral neuropathic pain
Qutenza
capsaicin patch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qutenza
capsaicin patch
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy
* diabetes mellitus
* treatment of face
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astellas Pharma s.r.o.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical and Scientific Affairs manager
Role: STUDY_DIRECTOR
Astellas Pharma s.r.o.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site CZ42019 Hospital
Benešov, , Czechia
Site CZ42026 Hospital
Beroun, , Czechia
Site CZ42008 Onco Clinic
Brno, , Czechia
Site CZ42001 Sv. Anna Hospital
Brno, , Czechia
Site CZ42007 Private Practice
České Budějovice, , Czechia
Site CZ42015 Hospital
Havlíčkův Brod, , Czechia
Site CZ42029 Hospital
Hořovice, , Czechia
Site CZ42009 University Hospital
Hradec Králové, , Czechia
Site CZ42004 Hospital
Jihlava, , Czechia
Site CZ42022 Hospital
Karlovy Vary, , Czechia
Site CZ42017 Hospital
Klatovy, , Czechia
Site CZ42025 Private Practice
Krnov, , Czechia
Site CZ42016 Hospital
Liberec, , Czechia
Site CZ42023 Hospital
Mladá Boleslav, , Czechia
Site CZ42020 Hospital
New Town, , Czechia
Site CZ42010 University Hospital
Olomouc, , Czechia
Site CZ42012 Hospital
Opava, , Czechia
Site CZ42002 University Hospital
Ostrava, , Czechia
Site CZ42006 University Hospital
Pilsen, , Czechia
Site CZ42013 Hospital
Prague, , Czechia
Site CZ42018 Rheumatological Institute
Prague, , Czechia
Site CZ42005 University Hospital
Prague, , Czechia
Site CZ42021 Military Hospital
Prague, , Czechia
Site CZ42027 Hospital
Semily, , Czechia
Site CZ42011 Hospital
Sokolov, , Czechia
Site CZ42024 Hospital
Teplice, , Czechia
Site CZ42028 Hospital
Uherské Hradiště, , Czechia
Site CZ42014 Private Practice
Vysoké Mýto, , Czechia
Site CZ42003 Bata Hospital
Zlín, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0805-MA-1001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.